Following is a summary of current health news briefs.
Weight-loss surgery between pregnancies tied to better outcomes
(Reuters Health) – Obese women who have weight-loss surgery between pregnancies may be less likely to experience complications like high blood pressure and preterm births in their second pregnancy, a recent study suggests. Researchers examined hospital records from 2002 to 2014 for more than 1.6 million women 15 to 45 years old in New South Wales, Australia. The study focused on 326 women who had bariatric surgery between their first and second pregnancies and 461,917 women who had two pregnancies without a weight-loss operation in between.
Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal
Bristol-Myers Squibb Co on Saturday said that an experimental cancer therapy it acquired as part of its $74 billion deal for Celgene Corp produced positive results in a clinical trial. The company said it will apply for U.S. approval for the treatment for a type of advanced blood cancer by the end of the year.
Malaysia reports first case of polio since 1992
A three-month-old Malaysian infant has been diagnosed with polio, the first case reported in the country in nearly three decades, a top health official said on Sunday. The baby boy from Tuaran in Malaysia’s Sabah state on Borneo island tested positive for polio on Friday after being admitted to hospital with a fever and muscle weakness, Director General of Health Noor Hisham Abdullah said in a statement.
Samoa says almost 90% of people vaccinated against measles after deadly outbreak
Samoa said on Saturday nearly 90% of eligible people had been vaccinated against measles as it lifted a two-day curfew imposed amid an outbreak that has killed 65 in recent weeks. There were, however, 103 new cases of measles reported since Friday, Samoa’s Health Ministry said it a statement.
Congo authorities say Ebola survivor falls ill a second time
An Ebola survivor has fallen ill with the disease for a second time in eastern Congo, the Congolese health authorities said on Sunday, saying it was not yet clear if it was a case of relapse or reinfection. The Ebola outbreak in Democratic Republic of Congo has infected over 3,300 people and killed more than 2,200 since the middle of last year, making it the second worst year on record.
Half of lymphoma patients alive three years after Gilead cell therapy treatment: study
Nearly half of lymphoma patients treated with Gilead Sciences Inc’s Yescarta were alive at least three years after a one-time infusion of the CAR-T cell therapy, according to data presented on Saturday. Out of 101 patients teated with Yescarta for an aggressive blood cancer known as refractory large B-cell lymphoma in the study, 47 were still alive at least three years later, the data presented at the American Society of Hematology meeting in Orlando showed.